COMMUNIQUÉS West-GlobeNewswire

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
01/02/2024
Bagsværd, Denmark, 1 February 2024 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons in accordance [...]
SweetWater Brewing and Pullman Yards Present 420 Fest on April 20 & 21, 2024
01/02/2024
SweetWater 420 Fest is Back Featuring 25+ Artists ATLANTA, Feb. 01, 2024 (GLOBE NEWSWIRE) -- SweetWater Brewing Company (“SweetWater Brewing” or “SweetWater”), the largest craft brewer in the Southeast and a subsidiary [...]
Crossject to host a business briefing on commercial strategy on February 6 at 17:30 CET
01/02/2024
Dijon, France, February 1, 2024 -- 18:15 CET - Crossject (ISIN: FR0011716265; Euronext: ALCJ), a specialty pharma company developing needle-free auto-injectors for emergency situations, will hold a conference call on [...]
Crossject organisera un webcast le 6 février à 17h30 pour faire le point sur sa stratégie commerciale
01/02/2024
Dijon, France, 1 février 2024 – 18 : 15 CET - Crossject (ISIN : FR0011716265 ; Euronext : ALCJ), une société pharmaceutique spécialisée qui développe des auto-injecteurs sans aiguille dédiés aux situations d’urgence, [...]
EssilorLuxottica: Full-Year 2023 Results Conference Call Invitation
01/02/2024
Full-Year 2023 Results Conference Call Invitation Mr FRANCESCO MILLERI, Chairman and Chief Executive Officer, Mr PAUL DU SAILLANT, Deputy Chief Executive Officer, Mr STEFANO GRASSI, Chief Financial Officer, and Mr [...]
Number of votings rights as of January 31 2024
01/02/2024
Nicox SA Société anonyme with a registered capital of € 50,186,094 Head Office: DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis  R.C.S. GRASSE 403.942.642 On February 1st, 2024, MONTHLY PUBLICATION OF [...]
Nombre de droits de vote au 31 janvier 2024
01/02/2024
Nicox SA Société anonyme au capital de 50 186 094 euros Siège social : DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis  R.C.S. GRASSE 403.942.642 Le 1er février 2024, PUBLICATION MENSUELLE DU NOMBRE D’ [...]
GT Biopharma, Inc. Announces 1-for-30 Reverse Stock Split
01/02/2024
BRISBANE, CALIFORNIA, Feb. 01, 2024 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (NASDAQ: GTBP) (the “Company”), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's [...]
Alira Health Releases Global Report on Robotic-Assisted Surgery (RAS) in Orthopedic Procedures
01/02/2024
Analysis reveals the market is anticipated to grow 10% annually over the next five years, reaching more than 2.6 million procedures in the EU, UK and US alone FRAMINGHAM, Mass., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Alira [...]
Enlitic® Announces Appointment of Steve Rankin as Chief Strategy Officer
01/02/2024
Rankin to drive Enlitic’s product and market strategies for future growth. FORT COLLINS, Colo. and MELBOURNE, Australia, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Enlitic, Inc. , (ASX:ENL) a leading innovator in data [...]
Myriad Genetics Completes Acquisition of Precise Tumor, Precise Liquid and Laboratory from Intermountain Precision Genomics
01/02/2024
SALT LAKE CITY, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced it has completed the acquisition from Intermountain Health of [...]
Evaxion Biotech Announces Pricing of $15 Million Public Offering
01/02/2024
COPENHAGEN, Denmark, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, today [...]
Oncternal Therapeutics Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
01/02/2024
SAN DIEGO, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced the approval [...]
Our Place Celebrates 2023 Community Impact Milestones and Looks Ahead to Further Outreach in 2024
01/02/2024
The New York-based nonprofit organization for at risk youth struggling with addiction and substance abuse saw record attendance and community outreach in 2023 NEW YORK, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Our Place (the “ [...]
Parexel Appoints Susan R. Salka to Board of Directors
01/02/2024
Ms. Salka brings more than 30 years of healthcare leadership and staffing expertise, including strong C-suite, financial and ESG expertise to advance the company’s Patients-first focus and growth initiatives DURHAM, N.C [...]
Celularity Announces Net Sales Expectations for First Quarter 2024 and Full Year 2024, Reiterates Advanced Biomaterial Product Commercial and Development Pipeline
01/02/2024
Continuing the substantial growth trajectory that began during 2023, for the first quarter 2024 and the full year 2024, Celularity expects triple-digit percentage increases in combined net sales of its advanced [...]
HeartSciences Appoints New Scientific Advisory Board Member
01/02/2024
Southlake, TX, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company") , an artificial intelligence (AI)-powered medical technology [...]
SPR® Therapeutics Announces $85 Million in Additional Funding to Advance Rapid Commercial Expansion of the SPRINT® PNS System
01/02/2024
CLEVELAND, Feb. 01, 2024 (GLOBE NEWSWIRE) -- SPR Therapeutics, a private medical device company focused on treating pain and improving the quality of life for patients managing acute or chronic pain, today announced [...]
Pressure BioSciences Upcoming Investor Call to Discuss Recent Acquisition of Uncle Buds
01/02/2024
Uncle Bud’s 2024 Revenue Expected to Increase 3-Fold to Approximately $5 Million, Fueled by UltraShear Processed Nanoemulsion Product Introductions and Exciting New Market Opportunities SOUTH EASTON, Mass., Feb. 01, [...]

Pages